CTNNB1 Alterations Affect Outcomes in Patients With HCC
CTNNB1 alterations affect outcomes in patients with hepatocellular carcinoma (HCC).
CTNNB1 alterations affect outcomes in patients with hepatocellular carcinoma (HCC).
Black patients with HCC are less likely than White patients to receive curative treatment.
While patients with hepatocellular carcinoma largely felt independent, their caregivers reported burdens related to appointment logistics and emotional support.
HCC survival time is predicted by albumin-bilirubin grade, microvascular invasion, and distant metastases.
The following is a summary of “Survival outcomes with adjuvant immunotherapy after hepatic...
The following is a summary of “Identification of a predictive phosphoproteomic signature of...
The following is a summary of “Identification of molecular subtypes for integrated multi-omics...
The following is a summary of “Atezolizumab + bevacizumab versus lenvatinib as first-line...
Researchers at the 2024 ASCO Annual Meeting found racial and ethnic disparities in palliative care use among patients with advanced hepatocellular carcinoma.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.